NFKB1 and neoplasm: Consistently, aspirin (100–400 mg/kg) inactivates NF-κB in vivo in two mouse models of CRC, namely, the HT-29-derived xenograft model and the ApcMin/+ mice, and this effect is paralleled by the induction of apoptosis in tumor cells [32].